Selected research
Industry Growth & Trends
Global Vasopressin V1b Receptor Industry Growth and Trends Forecast to 2032
Market perspective
The global Vasopressin V1b Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Vasopressin V1b Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Vasopressin V1b Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Vasopressin V1b Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Vasopressin V1b Receptor include Allergan Plc, AbbVie Inc., Orphan Therapeutics, LLC, Laboratorio ELEA S.A.C.I.F. y A. and Azevan Pharmaceuticals, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Vasopressin V1b Receptor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Vasopressin V1b Receptor market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vasopressin V1b Receptor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vasopressin V1b Receptor.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Vasopressin V1b Receptor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Vasopressin V1b Receptor Market by Company
Allergan Plc
AbbVie Inc.
Orphan Therapeutics, LLC
Laboratorio ELEA S.A.C.I.F. y A.
Azevan Pharmaceuticals, Inc.
Vasopressin V1b Receptor Segment by Type
ABT-436
AVN-628
PHT-103
Others
Vasopressin V1b Receptor Segment by Application
Hospital
Clinic
Others
Vasopressin V1b Receptor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vasopressin V1b Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vasopressin V1b Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vasopressin V1b Receptor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vasopressin V1b Receptor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Vasopressin V1b Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ABT-436
- AVN-628
- PHT-103
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Allergan Plc
- AbbVie Inc.
- Orphan Therapeutics, LLC
- Laboratorio ELEA S.A.C.I.F. y A.
- Azevan Pharmaceuticals, Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Vasopressin V1b Receptor Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Vasopressin V1b Receptor Sales Estimates and Forecasts (2021-2032)
- 1.3 Vasopressin V1b Receptor Market by Type
- 1.3.1 ABT-436
- 1.3.2 AVN-628
- 1.3.3 PHT-103
- 1.3.4 Others
- 1.4 Global Vasopressin V1b Receptor Market Size by Type
- 1.4.1 Global Vasopressin V1b Receptor Market Size Overview by Type (2021-2032)
- 1.4.2 Global Vasopressin V1b Receptor Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Vasopressin V1b Receptor Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Vasopressin V1b Receptor Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Vasopressin V1b Receptor Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Vasopressin V1b Receptor Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Vasopressin V1b Receptor Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Vasopressin V1b Receptor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Vasopressin V1b Receptor Industry Trends
- 2.2 Vasopressin V1b Receptor Industry Drivers
- 2.3 Vasopressin V1b Receptor Industry Opportunities and Challenges
- 2.4 Vasopressin V1b Receptor Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Vasopressin V1b Receptor Revenue (2021-2026)
- 3.2 Global Top Players by Vasopressin V1b Receptor Sales (2021-2026)
- 3.3 Global Top Players by Vasopressin V1b Receptor Price (2021-2026)
- 3.4 Global Vasopressin V1b Receptor Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Vasopressin V1b Receptor Major Company Production Sites & Headquarters
- 3.6 Global Vasopressin V1b Receptor Company, Product Type & Application
- 3.7 Global Vasopressin V1b Receptor Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Vasopressin V1b Receptor Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Vasopressin V1b Receptor Players Market Share by Revenue in 2025
- 3.8.3 2025 Vasopressin V1b Receptor Tier 1, Tier 2, and Tier 3
4 Vasopressin V1b Receptor Regional Status and Outlook
- 4.1 Global Vasopressin V1b Receptor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Vasopressin V1b Receptor Historic Market Size by Region
- 4.2.1 Global Vasopressin V1b Receptor Sales in Volume by Region (2021-2026)
- 4.2.2 Global Vasopressin V1b Receptor Sales in Value by Region (2021-2026)
- 4.2.3 Global Vasopressin V1b Receptor Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Vasopressin V1b Receptor Forecasted Market Size by Region
- 4.3.1 Global Vasopressin V1b Receptor Sales in Volume by Region (2027-2032)
- 4.3.2 Global Vasopressin V1b Receptor Sales in Value by Region (2027-2032)
- 4.3.3 Global Vasopressin V1b Receptor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Vasopressin V1b Receptor by Application
- 5.1 Vasopressin V1b Receptor Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Vasopressin V1b Receptor Market Size by Application
- 5.2.1 Global Vasopressin V1b Receptor Market Size Overview by Application (2021-2032)
- 5.2.2 Global Vasopressin V1b Receptor Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Vasopressin V1b Receptor Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Vasopressin V1b Receptor Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Vasopressin V1b Receptor Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Vasopressin V1b Receptor Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Vasopressin V1b Receptor Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Vasopressin V1b Receptor Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Allergan Plc
- 6.1.1 Allergan Plc Company Information
- 6.1.2 Allergan Plc Business Overview
- 6.1.3 Allergan Plc Vasopressin V1b Receptor Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Allergan Plc Vasopressin V1b Receptor Product Portfolio
- 6.1.5 Allergan Plc Recent Developments
- 6.2 AbbVie Inc.
- 6.2.1 AbbVie Inc. Company Information
- 6.2.2 AbbVie Inc. Business Overview
- 6.2.3 AbbVie Inc. Vasopressin V1b Receptor Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 AbbVie Inc. Vasopressin V1b Receptor Product Portfolio
- 6.2.5 AbbVie Inc. Recent Developments
- 6.3 Orphan Therapeutics, LLC
- 6.3.1 Orphan Therapeutics, LLC Company Information
- 6.3.2 Orphan Therapeutics, LLC Business Overview
- 6.3.3 Orphan Therapeutics, LLC Vasopressin V1b Receptor Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Orphan Therapeutics, LLC Vasopressin V1b Receptor Product Portfolio
- 6.3.5 Orphan Therapeutics, LLC Recent Developments
- 6.4 Laboratorio ELEA S.A.C.I.F. y A.
- 6.4.1 Laboratorio ELEA S.A.C.I.F. y A. Company Information
- 6.4.2 Laboratorio ELEA S.A.C.I.F. y A. Business Overview
- 6.4.3 Laboratorio ELEA S.A.C.I.F. y A. Vasopressin V1b Receptor Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Laboratorio ELEA S.A.C.I.F. y A. Vasopressin V1b Receptor Product Portfolio
- 6.4.5 Laboratorio ELEA S.A.C.I.F. y A. Recent Developments
- 6.5 Azevan Pharmaceuticals, Inc.
- 6.5.1 Azevan Pharmaceuticals, Inc. Company Information
- 6.5.2 Azevan Pharmaceuticals, Inc. Business Overview
- 6.5.3 Azevan Pharmaceuticals, Inc. Vasopressin V1b Receptor Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Azevan Pharmaceuticals, Inc. Vasopressin V1b Receptor Product Portfolio
- 6.5.5 Azevan Pharmaceuticals, Inc. Recent Developments
7 North America by Country
- 7.1 North America Vasopressin V1b Receptor Sales by Country
- 7.1.1 North America Vasopressin V1b Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Vasopressin V1b Receptor Sales by Country (2021-2026)
- 7.1.3 North America Vasopressin V1b Receptor Sales Forecast by Country (2027-2032)
- 7.2 North America Vasopressin V1b Receptor Market Size by Country
- 7.2.1 North America Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Vasopressin V1b Receptor Market Size by Country (2021-2026)
- 7.2.3 North America Vasopressin V1b Receptor Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Vasopressin V1b Receptor Sales by Country
- 8.1.1 Europe Vasopressin V1b Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Vasopressin V1b Receptor Sales by Country (2021-2026)
- 8.1.3 Europe Vasopressin V1b Receptor Sales Forecast by Country (2027-2032)
- 8.2 Europe Vasopressin V1b Receptor Market Size by Country
- 8.2.1 Europe Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Vasopressin V1b Receptor Market Size by Country (2021-2026)
- 8.2.3 Europe Vasopressin V1b Receptor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Vasopressin V1b Receptor Sales by Country
- 9.1.1 Asia-Pacific Vasopressin V1b Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Vasopressin V1b Receptor Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Vasopressin V1b Receptor Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Vasopressin V1b Receptor Market Size by Country
- 9.2.1 Asia-Pacific Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Vasopressin V1b Receptor Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Vasopressin V1b Receptor Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Vasopressin V1b Receptor Sales by Country
- 10.1.1 South America Vasopressin V1b Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Vasopressin V1b Receptor Sales by Country (2021-2026)
- 10.1.3 South America Vasopressin V1b Receptor Sales Forecast by Country (2027-2032)
- 10.2 South America Vasopressin V1b Receptor Market Size by Country
- 10.2.1 South America Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Vasopressin V1b Receptor Market Size by Country (2021-2026)
- 10.2.3 South America Vasopressin V1b Receptor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Vasopressin V1b Receptor Sales by Country
- 11.1.1 Middle East and Africa Vasopressin V1b Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Vasopressin V1b Receptor Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Vasopressin V1b Receptor Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Vasopressin V1b Receptor Market Size by Country
- 11.2.1 Middle East and Africa Vasopressin V1b Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Vasopressin V1b Receptor Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Vasopressin V1b Receptor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Vasopressin V1b Receptor Value Chain Analysis
- 12.1.1 Vasopressin V1b Receptor Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Vasopressin V1b Receptor Production Mode & Process
- 12.2 Vasopressin V1b Receptor Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Vasopressin V1b Receptor Distributors
- 12.2.3 Vasopressin V1b Receptor Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst